Similarly, CD161+γδT cells were enriched in the liver of NAFLD patients, suggesting that γδT cells produced by IL-17A are important regulatory factors for the progression of NAFLD [156]. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.